Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Glaucoma
Interventions
DRUG

Prostaglandin Analogue -Containing IOP-Lowering Therapy

Subjects with glaucoma may be prescribed prostaglandin analogs as part of their clinical care. This group will be observed longitudinally to assess changes in corneal biomechanics.

DRUG

Beta Blocker

Subjects with glaucoma may be prescribed topical beta blockers as part of their clinical care. This group will be observed longitudinally to assess changes in corneal biomechanics.

DEVICE

Brillouin Microscopy

Brillouin microscopy is a non-contact optical imaging method used to assess the biomechanical properties of the cornea in vivo with three-dimensional resolution. It will be used to evaluate corneal stiffness in all study subjects.

Trial Locations (1)

21201-1757

RECRUITING

University of Maryland School of Medicine, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

collaborator

National Eye Institute (NEI)

NIH

NCT06993597 - Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy | Biotech Hunter | Biotech Hunter